Arctic Bioscience AS (OSL:ABS)
Norway flag Norway · Delayed Price · Currency is NOK
3.300
+0.300 (10.00%)
May 13, 2026, 4:25 PM CET

Arctic Bioscience AS Income Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
40.143.4833.7534.2721.52
Other Revenue
2.530.920.010.20
42.6244.433.7634.4721.52
Revenue Growth (YoY)
-4.01%31.55%-2.07%60.21%4.48%
Cost of Revenue
29.0531.623.9822.6315.72
Gross Profit
13.5712.819.7811.845.8
Selling, General & Admin
24.4125.9523.5121.6917.26
Other Operating Expenses
17.4829.529.4721.1525.96
Operating Expenses
47.0160.658.3746.5745.74
Operating Income
-33.45-47.79-48.59-34.73-39.94
Interest Expense
-9.09-3.15-0.99-0-0.34
Interest & Investment Income
2.062.053.741.890.12
Other Non Operating Income (Expenses)
-0.550.950.331.47-1.78
EBT Excluding Unusual Items
-41.03-47.93-45.51-31.36-41.94
Other Unusual Items
----2.66-0.64
Pretax Income
-41.03-47.93-45.51-34.02-42.58
Net Income
-41.03-47.93-45.51-34.02-42.58
Net Income to Common
-41.03-47.93-45.51-34.02-42.58
Shares Outstanding (Basic)
2725252424
Shares Outstanding (Diluted)
2725252424
Shares Change (YoY)
6.42%-0.26%3.88%0.60%75.31%
EPS (Basic)
-1.52-1.89-1.79-1.39-1.75
EPS (Diluted)
-1.52-1.89-1.79-1.39-1.75
Free Cash Flow
-45.4-96.17-65.07-83.96-76
Free Cash Flow Per Share
-1.68-3.79-2.56-3.43-3.12
Gross Margin
31.84%28.84%28.97%34.36%26.95%
Operating Margin
-78.47%-107.63%-143.93%-100.75%-185.63%
Profit Margin
-96.25%-107.95%-134.83%-98.71%-197.90%
Free Cash Flow Margin
-106.52%-216.58%-192.78%-243.58%-353.22%
EBITDA
-28.33-44.9-43.2-31-37.42
EBITDA Margin
-66.46%-101.12%-127.99%-89.92%-173.92%
D&A For EBITDA
5.122.895.383.732.52
EBIT
-33.45-47.79-48.59-34.73-39.94
EBIT Margin
-78.47%-107.62%-143.93%-100.75%-185.63%
Revenue as Reported
42.6244.433.7634.4721.52
Source: S&P Global Market Intelligence. Standard template. Financial Sources.